RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single molecule and single cell analysis, today announced that the company has been recognized by the Museum of Science, Boston and the Boston Patent Law Association for its innovations and contributions to advancing the field of genetic research.
“The impact of this technology has the potential to dramatically advance the field of medical genetics research by uncovering novel information about both common diseases and rare health conditions.”
The "Invented Here!" program highlights New England's contribution to innovation in the fields of science and technology. By celebrating innovators, their inventions, and the stories behind them, the program aims to raise awareness about the art and business of invention. RainDance enables the high-resolution analysis of genetic variation, which is central to basic biomedical research, as well the rapidly advancing field of personalized medicine.
"The RainDance microdroplet technology represents a true breakthrough that is changing the way research scientists study the underlying genetic basis of human health and disease," said Michael Hunkapiller, Ph.D., Partner at Alloy Ventures and RainDance Board member. "The impact of this technology has the potential to dramatically advance the field of medical genetics research by uncovering novel information about both common diseases and rare health conditions."
RainDance Technologies was founded by scientists from Harvard University including Darren Link, Ph.D. who serves as the company's Vice President of Research and Development. Dr. Link is a physicist by training and has co-authored more than 60 peer-reviewed articles and 20 patent applications in microfluidics.
"RainDance is honored to be recognized along with other innovative companies that hail from New England, a region with a long history of catalyzing local ingenuity into solutions that solve important problems and create jobs," said Roopom Banerjee, President and CEO of RainDance Technologies. "We are proud of the contribution our microdroplet-based technology is making to the field of medically important genetics research and are committed to continually driving innovation that makes significant contributions to improving global health."
Finalists were chosen by a panel of New England-based leaders in technology, industry, business, academia, and law who evaluated applicants on the transformative nature of their inventions and their impact to the field of focus. RainDance and other finalists will be recognized during a celebration on February 15, 2011 at the Museum of Science, Boston. For more information, please visit the Invented Here! website.
New genetic insights: Sugary beverages linked to higher risk of atrial fibrillation